Accuray Inc

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $206.46M
  • PE -12
  • Debt $179.77M
  • Cash $61.13M
  • EV $325.10M
  • FCF -$14.24M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$16.53M
EBIT-$3.86M
ROE-37%
ROA-1%
FCF-$14.24M
Equity$45.22M
Growth Stability1
PE-12.49
PEG-34.56
PB4.57
P/FCF-14.5
P/S0.46
Price/Cash0.3
Debt/Equity3.98
Debt/FCF-12.63
Net Margins-4%
Gross Margins31%
Op. Margins-1%
Earnings CAGR0%
Sales Growth YoY-2%
Sales Growth QoQ-24%
Sales CAGR2%
FCF CAGR1%
Equity CAGR-2%
Earnings Stability0
Earnings Growth YoY33%
Earnings Growth QoQ-217%
Earnings CAGR 5Y0%
Sales CAGR 5Y3%
FCF CAGR 5Y-8%
Equity CAGR 5Y-8%
Earnings CAGR 3Y2%
Sales CAGR 3Y2%
FCF CAGR 3Y-7%
Equity CAGR 3Y-6%
Market Cap$206.46M
Revenue$444.20M
Assets$473.08M
Total Debt$179.77M
Cash$61.13M
Shares Outstanding100.23M
EV325.1M
Earnings Score6%
Moat Score10%
Safety Score57%
Final Score24%
Working Capital127.74M
Current Ratio1.63
Gross Profit$137.90M
Shares Growth 3y3%
Equity Growth QoQ0%
Equity Growth YoY-11%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.

SEC Filings

Direct access to Accuray Inc (ARAY) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-Q Dec 31
    • 10-Q Sep 30
    • 10-K Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Accuray Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Accuray Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%
Stability 0%
loading chart...

Accuray Inc Discounted Cash Flow

Fully customizable DCF calculator online for Accuray Inc.

= -$148M
012345678910TV
fcf-$14M-$14M-$14M-$14M-$15M-$15M-$15M-$15M-$15M-$15M-$15M-$151M
DCF-$13M-$12M-$11M-$10M-$9.1M-$8.3M-$7.6M-$7M-$6.4M-$5.8M-$58M
Value-$148M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Net Margins-11%-6%-8%-6%-4%1%-2%-1%-2%-3%-4%
ROA--1%-2%-1%0%3%5%2%0%0%-1%
ROE--43%-64%-49%-33%6%-9%-10%-17%-34%-37%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024TTM
Debt over FCF-10.2-51.6712.33-5.19-40.25.71-27.0463.49-11.72-12.63
Debt over Equity2.844.356.013.063.543.1833.623.464.033.98
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years06/201506/201606/201706/201806/201906/202006/202106/202206/202306/2024CAGR 5Y
Revenue YoY growth-5%-4%6%3%-9%3%8%4%-0%3%
Earnings YoY growth--37%16%-19%-31%-123%-265%-15%74%68%0%
Equity YoY growth--21%-22%5%3%28%8%-23%1%-16%-8%
FCF YoY growth--202%-121%-323%-382%-85%-820%-120%-141%-630%-8%